Cyril Zivré MBA                                     

Investment Director

Cyril joined Candover in 1998, initially working for the Chevrillon-Candover joint venture. Cyril joined from Generale de Sante where he was responsible for M&A activity. Cyril was part of the Candover team working on the buyout of Picard Surgelés, and most recently he was responsible for the buyout of Qioptiq, where he remains closely involved.  He is also currently working with Alma.

He is a French national and has country responsibility for France.  He holds an MBA from Ecole Superieure de Commerce and qualified as a chartered accountant with Coopers & Lybrand in 1988.